NCT01805427View on ClinicalTrials.gov

Antiretroviral Therapy and Extreme Weight

CompletedOBSERVATIONAL
Enrollment

140

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

November 30, 2013

Study Completion Date

November 30, 2013

Conditions
HIV Infection
Trial Locations (1)

75010

Hopital Lariboisiere, Paris

All Listed Sponsors
lead

Hopital Lariboisière

OTHER

NCT01805427 - Antiretroviral Therapy and Extreme Weight | Biotech Hunter | Biotech Hunter